Makarenko E V, Kozlovskiĭ I V
Ter Arkh. 1987;59(2):98-100.
A decrease in sodium, potassium and anion (HCO3)-activated erythrocyte ATPases is noted in patients with acute viral hepatitides A and B, chronic persisting hepatitis, liver cirrhosis, chronic cholecystitis and in HBs-antigen carriers, the reduction of HCO8-ATPase being more noticeable. A degree of expression of the above changes depends on the severity of a pathological process in the liver. The most serious changes are noted in liver cirrhosis. In this disease calcium ATPase activity is also on a decrease. Erythrocyte ATPase activity is lowered in chronic cholecystitis to a lesser degree. In patients with chronic persisting hepatitis and liver cirrhosis erythrocyte ATPase activity slightly increases, however it remains significantly lowered as compared to the control level. The determination of erythrocyte ATPase activity can be used for assessment of the status of patients with acute and chronic liver diseases.
在甲型和乙型急性病毒性肝炎、慢性持续性肝炎、肝硬化、慢性胆囊炎患者以及乙肝表面抗原携带者中,钠、钾和阴离子(HCO₃)激活的红细胞ATP酶活性降低,其中HCO₈ - ATP酶的降低更为明显。上述变化的表达程度取决于肝脏病理过程的严重程度。肝硬化中变化最为严重。在这种疾病中,钙ATP酶活性也降低。慢性胆囊炎患者红细胞ATP酶活性降低程度较小。慢性持续性肝炎和肝硬化患者的红细胞ATP酶活性略有增加,但与对照水平相比仍显著降低。测定红细胞ATP酶活性可用于评估急慢性肝病患者的状况。